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Gramicidin S is especially active against Gram-positive bacteria; e.g., Staphylococcus aureus. An analog, 
[4,4’-D-diaminopropionic acidlgramicidin S, which contains D-diaminopropionic acid residues instead of 
D-phenylalanine residues, has been synthesized. This analog is active against some of the Gram-negative 
bacteria; e.g., Escherichia coli and Salmonella typhosa. Activities of several related analogs are discussed. 
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1. INTRODUCTION 
Gramicidin S (fig.1) is a cyclic decapeptide an- 
tibiotic and exhibits high activity against Gram- 
positive bacteria such as Bacillus subtilis and 
Staphylococcus aureus [l]. Its decapeptide 
backbone holds a rigid p-sheet structure stabilized 
with 4 intramolecular hydrogen bonds as shown in 
fig. 1. This conformation gives a cationic 
detergent-like character to the peptide [2]. In the 
course of studies on structure-activity relation- 
ships of gramicidin S, we synthesized analogs con- 
taining D-2,3-diaminopropionic acid (D-Azpr) 
residues at 4,4’ positions in order to study the role 
of two additional cationic residues on antibacterial 
t To whom correspondence should be addressed 
Abbreviations: see IUPAC-IUB Commissions (1974) 
Pure Appl. Chem. 40, 317-331; Others: EDC, 
l-ethyl-3-(3-dimethylaminopropyl) carbodiimide; HO- 
NSu, N-hydroxysuccinimide; TFA, trifluoroacetic acid 
activity. We synthesized also an analog containing 
a,,&dehydroalanine (AAla) residues at 4,4’ posi- 
tions from the analog containing D-Azpr residues. 
2. EXPERIMENTAL 
Molecular mass was determined on a JEOL 
JMS-DX 300 mass spectrometer. CD spectra were 
recorded on a JASCO J-40A automatic recording 
spectropolarimeter in methanol. 
The route for the synthesis of [L- 
0rn(HC0)2*2’, D-Azpr(Z)4$4’]gramicidin S is 
shown in fig.2. The peptide chain was elongated 
stepwise by use of Boc-amino acid active ester and 
successive TFA treatment until protected pen- 
tapeptide I was obtained. The C-terminus in in- 
termediate linear pentapeptide was w-formyl-l- 
ornithine. One half of compound I was converted 
to active ester II, and another half was treated with 
TFA to give pentapeptide trifluoroacetate 
III-TFA. Coupling of II with III afforded 
decapeptide (IV) (82%), which was again con- 
verted to active ester, treated with TFA, and then 
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Fig.1. Structure of gramicidin S. 
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Fig.2. Synthesis of [L-Orn(HCO)z~Z’, D-A2pr(Z)4*4’]gramicidin S. 
subjected to cyclization in pyridine at 3 mM of V. 
Purification with Amberlite CC-SO, Dowex 1, and 
silica gel column chromatography yielded [L- 
0rn(HC0)292‘, D-Azpr(Z)4*4’Jgramicidin S(V1) 
(39% from IV). 
Treatment of VI with 0.5 M HCl in methanol 
for 3 days gave [D-Azpr(Z)4,4’]gramicidin S-2 
HCl (VII-2 HCl) (75070, M, (m + 1)’ 1288, calcd 
(m + 1)+1288). Hydrogenolysis of VII removed the 
Z groups to give [D-A~pr4,4’]gramicidin S-4 HCl 
(VIII-4 HCl) (76Yo). Treatment of VII with 
@oc)zO t31 afforded [L-0rn(Boc)2*2’, 
D-Azpr(Z)4,4’]gramicidin S (IX) (52%). Hydro- 
genolysis of IX gave [L-0rn(Boc)2v2’, D-A2pr4*4’]- 
gramicidin S-2 HCl (X-2 HCl) (95%), which was 
treated with CH3I and KHC03 as in [4,51 to give 
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Table 1 
Antimicrobial activity of grarnicidin S analogs 
Organism Minimum inhibitory concentration @g/ml) 
GS VII VIII X XII 
Staphylococcus aureus FDA 209P 
Bacillus subtilis PC1 219 
~scher~ch~ coli NIHJ JC-2 
Salmonella typhosa Boxhill 58 
Shigella jkxneri EW-10 
Shigella sonnei EW-33 
Klebsiella pneumoniae DT 
Proteus vulgaris IF0 3988 
6.25 6.25 
3.13 3.13 
>lOu >lOO 
>lOO >lOO 
6.25 6.25 
100 >lOO 
12.5 50 
>I00 >I00 
100 >lOO 12.5 
12.5 >I00 6.25 
25 >lOO >100 
25 >lOO >lOO 
25 >lOO 50 
50 >lOO 100 
50 >lOO 25 
>lOO >lOO >I00 
[L-0rn(Boc)2’2’ , AAla4*4’]gramicidin S (XI) (74%). 
This was treated with TFA to yield 
[AAla4*4’ Jgramicidin S-2 TFA (XII-2 TFA) 
(88Q/o). All crystalline compounds gave satisfactory 
elemental analyses. 
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Fig.3. CD curves of gramicidin S analogs. Solvent: 
MeOH. Curve: (- ) gramicidin S; (- - -) VII; 
(-*-‘-) VIII; (_“_x_) x; (-“‘_“._) XII. 
3. RESULTS 
Results of the microbial assay are shown in table 
1. Gramicidin S and compound VII show similar 
activities against Gr~-positive bacteria and 
Shigelra flexneri. On the other hand, compound 
VIII shows moderate activity against several 
Gram-negative bacteria including Escherichia coli 
but negligible activity against Gram-positive 
bacteria such as St~~hy~ococ~ aureus. Unex- 
pectedly, compound XII shows high activity com- 
parable to that of gramicidin S. 
Fig.3 shows CD curves of gramicidin S and syn- 
thesized analogs. Characteristic features (troughs 
at about 205 and 215 nm) for gramicidin S are 
essentially preserved for VII, VIII and X. 
However, the intensity of the troughs was con- 
siderably decreased for VIII. Proximity of the 4 ca- 
tionic charges may cause some disturbance in the 
backbone conformation. The CD curve of XII 
shows a trough at 222 nm, signifying change in 
conformation due to incorporation of AAla 
residues. 
4. DISCUSSION 
Dozens of amino acid-substituted analogs are 
synthesized for gramicidin S. All active analogs 
hold similar cationic detergent-like characters [2]. 
Analogs containing D-Azpr residues also conserve 
the common character as suggested by similarity of 
CD curves. Complete inactivity of X suggests that 
the side-chain length of D-Azpr is too short to in- 
teract with bacteria. 
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Compound VIII showed activity against some of I21 lzumiya, N., Kato, T., Aoyani, H.. Waki. M. and 
Gram-negative bacteria. As the conformations of 
VIII and gramicidin S seem to be similar, the 
change in the activity should be due to the increase 
of cationic charges at the hydrophilic side of the 
molecule. It should be noted here that polymyxins, 
known by their high activity against Gram- 
negative bacteria, contain 6 basic amino acid 
residues out of 10 component amino acid residues 
M. 
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